Company intelligence / Profile preview

Alters BioScience Consulting

Palo Alto, California, United Statesaltersbioscience.com ↗

Ownership: Private
Development stage: Other

Overview

Alters BioScience Consulting is a boutique consultancy with over 20 years of experience in biotechnology and drug development. The firm specializes in designing and implementing strategies for preclinical and translational drug development, including IND-enabling studies, PK/PD analysis, toxicology, and clinical trial planning. They have supported programs that have advanced from research through Phase 1–3 trials across small molecules, biologics, and enzyme therapeutics for oncology and rare diseases.

Therapeutic areas: OncologyRare DiseasesOther
Modalities: Small moleculeBiologicEnzyme therapeutic
Industry: Consulting

Partnerships

Not publicly disclosed; works with various biotech/pharma clients on a project basis

Beyond the preview

Go deeper on Alters BioScience Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alters BioScience Consulting.

Explore the full profile